Global Pharmaceutical Gelatin Market

Pharmaceutical Gelatin Overview:

Gelatin is a versatile material used in several pharmaceutical and biomedical applications worldwide due to its biocompatibility and easily digestible property. Gelatin is a basic excipient for the production of pharmaceutical medications. It is known as the ideal delivery vehicle for various medicines, drugs, and therapeutic agents. The pharmaceutical manufacturers make use of its unique adhesive, gelling and film-building functionalities. Dietary supplements and orally administered drugs, in particular, are protected by gelatin-containing capsules or tablets from moisture, oxygen & light and given a long shelf life. It is a protein that is derived from animal raw materials. It is obtained from the most abundant protein in the animal world through partial hydrolysis of collagen with high concentrations present in connective tissues. Currently, the gelatine-based delivery system has risen in popularity among grown-ups as fortified gummies.

Global Pharmaceutical Gelatin Market Insights

The global pharmaceutical gelatin market was valued at USD 1.07 billion in 2019 and is projected to reach USD 1.52 billion by 2027, growing at a CAGR of 5.25% from 2020-2027. The significant component is the growing demand for pharmaceutical gelatins is due to the versatility and unique functional properties of gelatin in pharmaceutical applications. Additionally, the increasing incidence of chronic diseases across the globe will spur the global pharmaceutical gelatin industry in future periods. Furthermore, the increase in the geriatric population and growing developments in the pharmaceutical sector are expected to witness the remarkable growth of pharmaceutical gelatin. The increasing consumption of oral dosage form, OTC products, and food supplements used to treat numerous diseases is expected to propel the demand for pharmaceutical gelatin over the coming years. Moreover, the upsurge in demand for fortified gummies instead of chalky or unpleasant chewable tablets and medicinal syrups among kids and adults is positively impacting the market for pharmaceutical gelatin in the healthcare industry. Furthermore, the rapid expansion in customer base, rise in the extensive R&D activities at the academic and industrial level, and increasing scope of biomedical applications are fueling the demand for the pharmaceutical gelatin market. The growing benefits of gelatin-based capsules and tablets, such as easy to swallow, safe dosage, convenient ingestion, and long shelf life, will bolster the global pharmaceutical gelatin market share growth. Additionally, the technological innovation for the development of cost-effective products and increasing healthcare demands in the developing world is propelling the growth of the pharmaceutical gelatin market across the globe.

Growth Driver

The rising importance of gelatin due to superior properties

Pharmaceutical gelatine is a versatile excipient that has been used in the pharmaceutical industry for decades. The critical application of gelatine is the production of hard & soft capsules and tablets. However, gelatine capsules are among the most popular dosage forms for drugs. The unique functional capabilities of gelatin, such as adhesion, binding, coating, gelling, and film-building, make it highly advantageous for the pharmaceutical industry. Gelatine is non-allergenic, highly compatible with other ingredients, and comprises proteins easily digested in the gastrointestinal tract, facilitating the release and absorption of active ingredients. Furthermore, the properties of gelatin protect against environmental changes associated with moisture or oxygen, thereby increasing the shelf-life of pharmaceutical products. However, the rising cost of unprocessed material and cultural restrictions about the consumption of porcine and bovine-derived gelatin can be a restraint to the market’s growth. However, the growing adoption of gelatin from natural sources will boost the market.

Source Segmental Analysis

Based on the source, the global pharmaceutical gelatin market is segregated into porcine, bovine skin, bovine bone, marine, and poultry. The porcine segment is estimated to witness the highest growth over the analysis timeframe. It is due to its wide applications across the pharmaceutical industry and in the hemostatic application to develop absorbable gelatin sponges. Porcine gelatin is made from fresh skin and is low in heavy metal and impurity; it has high clarity and low viscosity. It is the most commercially used gelatin globally due to its lower price and shorter manufacturing cycle. However, its applications are restricted in Islamic countries as it is not halal. The bovine skin segment will grow significantly due to the growing utilization in pharmaceutical and biomedical applications. Besides, it can be accepted as halal and kosher and complies with the law of Muslims and Jews.

Function Segmental Analysis

Based on the function, the global pharmaceutical gelatin market is categorized into stabilizing agents, thickening agents, and gelling agents & other parts. The thickening agent segment is held for a significant market share in 2019 and will gain maximum market revenue by 2027. It is attributable to its application in liquid dosage forms, including elixirs & medicinal syrups. In addition, gelatin is employed to increase the viscosity of the dosage form without altering its other properties, and increasing the utilization of gelatin as a thickening agent in lotions, and antibiotic creams drive market growth. The stabilizing agent segment is poised to witness significant growth over the forecast period. It is due to the growing use of purified gelatin used as a stabilizer in some vaccines. In addition, gelatin as a stabilizer helps to keep lyophilized products stable, ensures patient safety, and reduces the potential for side effects.

Application Segmental Analysis

Based on the application, the global pharmaceutical gelatin market is classified into hard capsules, soft capsules, tablets, absorbable hemostats, and other applications. The hard capsules are expected to be the highest revenue share for pharmaceutical gelatin during the forecast period. The segment’s growth is primarily attributed to its advantages, such as fewer manufacturing complexities, lower production costs, and secures excellent active pharmaceutical ingredient dissolution rates. In addition, gelatin is highly used in hard capsules due to its ability to protect sensitive ingredients from oxygen, microbial growth, light, and other forms of contamination. The absorbable hemostats segment will witness a lucrative growth rate in the estimated period due to the high use of gelatin in a medical device to stop bleeding and facilitate healing during and after surgical procedures.

Region Segmental Analysis

The global pharmaceutical gelatin market is segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa by geography. North America is estimated to project considerable patients over 2020-2026. Due to the presence of strict regulatory mandates across the region, ample availability of a porcine and bovine source of raw material, and the rapidly growing pharmaceutical sector. The Asia Pacific will capture a significant share of the gelatin market by 2027. It is due to the presence of leading industry players offering innovative products and increasing healthcare expenditure.

Competitor Analysis

Companies such as Gelita AG, Tessenderlo Group, Darling Ingredients Inc, Nitta Gelatin Inc, Xiamen Gelken Gelatin Co. Ltd, India Gelatine & Chemicals Ltd, Weishardt, Trobas Gelatine B.V., Lapi Gelatine S.p. A, Italgelatine S.p. A, Sterling Gelatin, Gelco International, Aspire Pharmaceuticals,  Gelnex Industria E Comercio Ltd, Geltech Co. Ltd, Geliko LLC, and Kenney & Ross Limited are the key players in the global pharmaceutical gelatin market.

Key Stakeholders

• Market research and consulting firms
• Industry associations
• Global pharmaceutical gelatin manufacturing firm
• Research organizations and consulting companies
• Organizations, associations, and alliances related to pharmaceutical gelatin
• Regulatory bodies
• Suppliers
• Retailers

The objective of the Research

• Market modeling begins with identifying a target market where historical data exists. A Market can include prediction problems, economic factors, analyzing customer behavior, and identifying new patterns from past events, which helps our client to have deep dive into the market.
• Product analysis involves examining product features, costs, availability, quality, and other aspects. Product analysis is conducted to understand potential buyers and measure competition in the market.
• Market Trend and Economic Factors Analysis helps assess potential changes to an economy’s inflation rate, taxes, interest rates, exchange rates, trading regulations, and excise duties that can or have a significant effect on the target market.
• Market Segmental Analysis defines an in-depth scenario of the target market by grouping consumers into naturally existing created segments of consumers who share similar product choices or characteristics.
• The geographical mapping approach helps our clients to understand national or international markets because different consumers in different regions have different needs, wants, and cultural characteristics that they can specifically target.

Market Modelling

By Source

• Porcine
• Bovine Skin
• Bovine Bone
• Marine
• Poultry

 By Function

• Stabilizing agents
• Thickening agents
• Gelling agents & Other Functions

 By Application

• Hard Capsules
• Soft Capsules
• Tablets
• Absorbable Hemostats
• Other Applications

 By Region

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Sensor Patch Market

Medical Simulation Market

Hospital EMR Systems Market

Global Exosomes Research Product Market

Global Stem Cell Manufacturing Market

Recombinant Cell Culture Supplements Market

Antibodies Reagents Market

UK, US, South Africa, Australia Equestrian Insurance Market

Global Synthetic Biology Market